Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration
Public ClinicalTrials.gov record NCT01458405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether Allogeneic Cardiosphere-Derived Cells (CAP-1002) is safe and effective in decreasing infarct size in patients with a myocardial infarction.
Study identification
- NCT ID
- NCT01458405
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 135 participants
Conditions and interventions
Conditions
Interventions
- CAP-1002 Allogeneic Cardiosphere-Derived Cells Biological
- Placebo Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 13, 2012 (Actual)
- Primary completion
- Jul 3, 2017 (Actual)
- Completion
- Feb 28, 2019 (Actual)
- Last update posted
- Apr 9, 2024
2012 – 2019
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology, P.C. | Birmingham | Alabama | 35211 | — |
| Heart Center Research | Huntsville | Alabama | 35801 | — |
| Scripps | La Jolla | California | 92037 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of Florida - Shands Hospital | Gainesville | Florida | 32610 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Prairie Heart - St. John's Hospital | Springfield | Illinois | 62712 | — |
| Kansas University Medical Center | Kansas City | Kansas | 66160 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| UMass Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| Michigan CardioVascular Institute | Saginaw | Michigan | 48602 | — |
| Metropolitan Heart and Vascular Institute / Mercy Hospital | Coon Rapids | Minnesota | 55433 | — |
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55407 | — |
| University at Buffalo | Buffalo | New York | 14203 | — |
| Lenox Hill Hospital | New York | New York | 10075 | — |
| Carolinas HealthCare System | Charlotte | North Carolina | — | — |
| Duke University Hospital | Durham | North Carolina | 27710 | — |
| NC Heart & Vascular Research | Raleigh | North Carolina | 27607 | — |
| SUMMA Health System | Akron | Ohio | 44304 | — |
| Lindner Center for Research and Education at the Christ Hospital | Cincinnati | Ohio | 45219 | — |
| Ohio State University | Columbus | Ohio | 43201 | — |
| OhioHealth Research Institute | Columbus | Ohio | 43214 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| The Miriam Hospital | Providence | Rhode Island | 02906 | — |
| Austin Heart | Austin | Texas | 78756 | — |
| University of Texas Memorial Hermann Hospital | Houston | Texas | 77030 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| University of Vermont Medical Center | Burlington | Vermont | 05401 | — |
| Swedish Medical Center - Heart and Vascular Research | Seattle | Washington | 98122 | — |
| University of Washington | Seattle | Washington | 98195 | — |
| Aurora Research Institute | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01458405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01458405 live on ClinicalTrials.gov.